Rosiglitazone and Exercise in Patients With Type 2 Diabetes Mellitus
Status:
Completed
Trial end date:
2006-10-01
Target enrollment:
Participant gender:
Summary
The aim of the present study is to investigate the influence of systemic exercise,
rosiglitazone administration and combined pharmaceutical and lifestyle intervention on
cardiovascular risk factors